Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OEA for Young Adults With Alcohol Use Disorder
NCT07503782Phase 2Not yet recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Nov 2026
- Primary completion
- Jun 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing OEA with Placebo (2 arms). Primary endpoints: Change in Peripheral IL-6 Concentration at 6 weeks, Change in Peripheral TNF-α Concentration at 6 weeks and 2 more. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
Oleoylethanolamide
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07503782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07503782.